*
*Cardiomyopathy|57809008
*
*
(literally "heart muscle disease"|57809008
)
is
the measurable deterioration
of the function|246464006
of the myocardium|74281007
(
the heart muscle|74281007
)
for any reason,|410666004
usually
leading|236874000
to heart failure|84114007|42343007
;
common symptoms|72906007
are
dyspnea|267036007
(breathlessness|267036007
)
and
peripheral edema|271809000
(swelling|423666004|442672001
of the legs|30021000
).

People|125676002
with cardiomyopathy|57809008
are
often at risk|70232002|30207005
of dangerous forms|246176004
of irregular heart beat|361138002
and
sudden cardiac death.|95281009

The most common form|4757001|72906007|246176004
of cardiomyopathy|57809008
is
dilated cardiomyopathy.[2][3]|195021004

Although
in theory
the term "cardiomyopathy"|57809008
could
apply|410618006|417924000
to almost
any disease|64572001
affecting|247591002|248448006
the heart,|80891009|302509004
in practice|52101004|18720000
it
is
usually
reserved
for "severe myocardial disease|24484000|57809008
leading|236874000
to heart failure".|84114007|42343007

Cardiomyopathies|57809008
can
be
categorized
as extrinsic|261074009|255400000
or
intrinsic.[5]|260521003|255406006

It
is
also possible to|371930009|60022001
classify|73504009
cardiomyopathies functionally,|57809008
as
involving|248448006
dilation,|25322007|71025006|363105001
hypertrophy,|56246009
or
restriction.[6]|263856008

Symptoms
and
signs|72670004
may
mimic
those
of almost
any
form|246176004
of heart disease.|56265001

Chest pain|29857009
is
common.|72906007

Mild myocarditis|255604002|50920009
or
cardiomyopathy|57809008
is
frequently asymptomatic|70232002|84387000
;
severe cases|24484000|398241000|24484000|413769002
are
associated|47429007
with heart failure,|84114007|42343007
arrhythmias,
and
systemic embolization.|31099001|122463005

Manifestations|250255003|251190009
of the underlying disease|64572001
(
e.g.
,
Chagas' disease|77506005
may
be
prominent.|4657009

Most patients|116154003
with biopsy-proven myocarditis|86273004|277025001|50920009
report|229059009|223458004
a recent viral prodrome|6493001|83931009
preceding|236874000
cardiovascular symptoms.|267037003

EKG abnormalities|276654001|29303009|276654001
are
often|70232002
present|52101004|246105001
,
although
the changes|243326001|263703002
are
frequently nonspecific.|70232002|10003008

A pattern|272135003
characteristic
of left ventricular hypertrophy|55827005|164873001
may
be
present.|52101004|246105001

Flat|6041008|257564005
or
inverted T waves|59931005
are
most common, often|4757001|72906007|70232002
with low-voltage QRS complexes.|62482003|164949005|371880002|164949005

Intraventricular conduction defects|4554005
and
bundle branch block,|6374002
especially left bundle branch block,|63467002
are
also common.|72906007

An echocardiogram|40701008
is
useful to
detect|260373001
wall motion abnormalities|224727009|56219004|276654001
or
a pericardial effusion.|373945007

Chest radiographs|399208008
can
be
normal|17621005|258744000
or
can
show
evidence|18669006
of congestive heart failure|42343007
with pulmonary edema|19242006
or
cardiomegaly.|8186001

Treatment|276239002|416118004
depends
on the type|261664005
of cardiomyopathy|57809008
and
condition|260905004
of disease,|64572001
but
may
include|55919000
medication|410942007
(conservative treatment|276239002|416118004
)
or
iatrogenic/implanted pacemakers|255405005|40388003|14106009
for slow heart rates,|48867003
defibrillators|19257004
for those prone|1240000
to fatal heart rhythms,|399166001|251149006
ventricular assist devices|360064003
(LVADs
)
for severe heart failure,|24484000|84114007|24484000|42343007
or
ablation|257729003|64597002
for recurring dysrhythmias|246455001|255227004
that
cannot
be
eliminated
by medication|410942007
or
cardioversion.|250980009

The goal|410518001
of treatment|276239002|416118004
is
often symptom relief,|70232002|224978009
and
some patients|116154003
may
eventually
require
a heart transplant.|32413006

Treatment|276239002|416118004
of cardiomyopathy|57809008
(
and
other heart diseases
)
using|260676000
alternative methods|260686004|272394005
such as stem cell therapy|418318001|276239002|419758009|276239002
is
commercially available|103328004
but
is
not
supported|9096001|243114000
by convincing evidence.|18669006

M
:
HRT|266717002

anat/phys/devp

noco/cong/tumr,
sysi/epon,
injr

proc,
drug|410942007
(C1A/1B/1C/1D,|264654002
blte

